76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Ekso Bionics Holdings
Closed
0.36 -16.28
Overview
Share price change
24h
Min
0.36
Max
0.43
Income | 522K -2.9M |
|---|---|
Sales | -1.7M 3.4M |
EPS | -0.12 |
Profit margin | -85.659 |
Employees | 61 |
EBITDA | -484K -3.4M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +455.56% upside |
Market Cap | -1.3M 12M |
|---|---|
Previous open | 16.64 |
Previous close | 0.36 |
Technical Score
By Trading Central
Confidence
Bearish Evidence
Ekso Bionics Holdings Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Ekso Bionics Holdings Forecast
Price Target
By TipRanks
455.56% upside
12 Months Forecast
Average 2.5 USD 455.56%
High 4 USD
Low 1 USD
Based on 2 Wall Street analysts offering 12 month price targets forEkso Bionics Holdings - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Ekso Bionics Holdings
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
